Dynavax Technologies | Despesas De Vendas E Administração

Selling And Administration Expenses Alterar Data
AbbVie USD 3.32B 291M 2024-03
Adma Biologics USD 15.64M 581.21K 2024-03
Amgen USD 1.81B 44M 2024-03
AstraZeneca USD 4.63B 100M 2024-03
Biogen USD 581.5M 27M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Dynavax Technologies USD 44.06M 4.27M 2024-03
Gilead Sciences USD 1.38B 233M 2024-03
Glaxosmithkline GBP 2.09B 500M 2024-03
Merck USD 2.48B 268M 2024-03
Neurocrine Biosciences USD 243.1M 38.9M 2024-03
Novartis USD 2.84B 604M 2024-03
Pfizer USD 3.5B 976M 2024-03
Regeneron Pharmaceuticals USD 689M 48.7M 2024-03
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 127M 6.11M 2024-03
TG Therapeutics USD 34.58M 3.43M 2024-03
Vertex Pharmaceuticals USD 342.7M 78.9M 2024-03



Dynavax Technologies Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.